Characterising the phenotypic evolution of circulating tumour cells during treatment.

about

Characterising the phenotypic evolution of circulating tumour cells during treatment.

Item

http://www.wikidata.org/entity/Q53694846

description

2018 nî lūn-bûn

@nan

2018年の論文

@ja

2018年学术文章

@wuu

2018年学术文章

@zh

2018年学术文章

@zh-cn

2018年学术文章

@zh-hans

2018年学术文章

@zh-my

2018年学术文章

@zh-sg

2018年學術文章

@yue

2018年學術文章

@zh-hant

name

Characterising the phenotypic evolution of circulating tumour cells during treatment.

@en

Characterising the phenotypic evolution of circulating tumour cells during treatment.

@nl

type

Item

label

Characterising the phenotypic evolution of circulating tumour cells during treatment.

@en

Characterising the phenotypic evolution of circulating tumour cells during treatment.

@nl

prefLabel

Characterising the phenotypic evolution of circulating tumour cells during treatment.

@en

Characterising the phenotypic evolution of circulating tumour cells during treatment.

@nl

P1476

Characterising the phenotypic evolution of circulating tumour cells during treatment

@en

P2093

Jing Wang

http://www.w3.org/2001/XMLSchema#string

Simon Chang-Hao Tsao

http://www.w3.org/2001/XMLSchema#string

P2860

Isolation of rare circulating tumour cells in cancer patients by microchip technology

Human melanoma-initiating cells express neural crest nerve growth factor receptor CD271

Improved survival with vemurafenib in melanoma with BRAF V600E mutation

CD146 expression is associated with a poor prognosis in human breast tumors and with enhanced motility in breast cancer cell lines

Polymerase chain reaction detection of melanoma cells in the circulation: relation to clinical stage, surgical treatment, and recurrence from melanoma

Tumor cells circulate in the peripheral blood of all major carcinomas but not in healthy subjects or patients with nonmalignant diseases

Probing Single Molecules and Single Nanoparticles by Surface-Enhanced Raman Scattering

Human CD271-positive melanoma stem cells associated with metastasis establish tumor heterogeneity and long-term growth

The molecular evolution of acquired resistance to targeted EGFR blockade in colorectal cancers

Function-Blocking ERBB3 Antibody Inhibits the Adaptive Response to RAF Inhibitor

P2888

s41467-018-03725-8

P304

1482

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/S41467-018-03725-8

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

P577

2018-04-16T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29662054

http://www.w3.org/2001/XMLSchema#string

P932

5902511

http://www.w3.org/2001/XMLSchema#string